Eureka
I have found it
Government Audit and Accountability of Federally Funded State-Administered Programs Act
The bill strengthens program integrity and aims to reduce improper payments through GAO assessments and federal recommendations, benefiting taxpayers and program sustainability, but it creates implementation costs and could tighten enrollment rules in ways that delay or restrict benefits for eligible low-income people.
Epstein Files Transparency Act
The bill substantially increases public access and congressional oversight of DOJ records (boosting transparency and accountability) but does so on rapid timelines that raise serious risks to victim privacy, ongoing prosecutions, national security, reputations of uncharged individuals, and DOJ resources.
Foreign Investment Review Monitoring and Commitment Tracking Oversight Board Act
The bill increases transparency, ethics oversight, and national‑security vetting of foreign investments and aims to steer deals toward U.S. jobs and resilient supply chains — but it does so at the cost of higher compliance and administrative burdens, potential deterrence of legitimate investment, privacy risks, and possible diplomatic or politicization side effects.
Critical Defense Ownership Review Act
The bill strengthens oversight of investments in major defense suppliers to protect national-security-critical supply chains and improve interagency visibility, at the cost of added compliance burdens, potential deal delays, and modest government reporting expenses that may deter some private investment.
Federal Biotechnology Workforce Assessment Act
The bill strengthens federal biotechnology workforce planning, training, and rapid access to expertise by clarifying roles and enabling exchanges, but it increases administrative work, raises privacy and conflict-of-interest risks, and may require additional funding.
Stop Deadly Denials Act of 2026
The bill prioritizes faster, simpler access to care for Medicare beneficiaries and reduced provider paperwork by limiting prior authorization in Medicare Advantage, at the expense of reduced utilization controls, potential higher Medicare spending, some administrative confusion, and constraints on CMS's ability to pilot new authorization models.
Gasoline Export Ban Act of 2026
The bill trades lower, more stable domestic gasoline prices for refiners and consumers against lost export revenue, greater industry uncertainty, potential trade retaliation, and disruption to global fuel markets.
End Polluter Welfare for Enhanced Oil Recovery Act of 2026
The bill simplifies tax administration and reduces a fossil-fuel related subsidy (aligning policy with climate goals), but it also removes tax benefits for EOR and certain carbon‑capture uses—raising costs for affected companies and risking higher energy prices and slower CCS deployment.
Big Oil Windfall Profits Tax Act
The bill funds quarterly cash rebates for low‑ and middle‑income households by imposing a windfall profits tax and dedicating related revenues—providing targeted relief to many but risking higher fuel prices, administrative burdens, and exclusions for some eligible households.
AI-Ready Bio-Data Standards Act
The bill promotes interoperable, transparent, and more secure AI‑ready biological datasets for federally supported research, but it increases compliance burdens, risks excluding smaller actors, and raises data privacy and governance concerns that must be managed.
